# Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome

> **NCT00152100** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 4 (actual)

## Conditions studied

- Severe Combined Immunodeficiency

## Interventions

- **PROCEDURE:** Stem cell transplant
- **DRUG:** Filgrastim, Alemtuzumab
- **DEVICE:** Miltenyi CliniMACS

## Key facts

- **NCT ID:** NCT00152100
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2009-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152100, "Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00152100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*